Karen Akinsanya - Mar 4, 2024 Form 4 Insider Report for Schrodinger, Inc. (SDGR)

Role
President of R&D, Therapeutics
Signature
/s/ Donald Shum, as attorney-in-fact for Karen Akinsanya
Stock symbol
SDGR
Transactions as of
Mar 4, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 04:44 PM
Previous filing
Jun 16, 2023
Next filing
Jun 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SDGR Stock Option (right to buy) Award $0 +120K $0.00 120K Mar 4, 2024 Common Stock 120K $25.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.